Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Tackling the genetic onset of Down syndrome

08.02.2010
Researchers at the RIKEN Brain Science Institute are developing a highly efficient system to create mouse model lines that could dramatically advance genetic research on the most common mental retardation.

Chromosome 21 is the smallest of the 23 pairs of chromosomes in humans, yet it is responsible for Down syndrome—the most common genetic mental retardation. Down syndrome (DS) is caused by the erroneous replication of human chromosome 21 (HC21), which results in three copies of the chromosome instead of the normal pair of two.

The most common cause of this ‘trisomy’ on HC21 is the failure of the chromosome pair to divide in an egg cell—often linked to advanced maternal age. Such an egg cell has two copies of HC21, and when fertilized, accepts another copy of HC21 from the sperm cell, resulting in a total of three, instead of the normal two, copies of the chromosome.

Unlocking the molecular pathology of trisomy 21 is greatly anticipated. Worldwide, it is estimated that up to one in every 700 babies is born with DS, and there are no specific therapeutic treatments. Yet little is known as to what determines the various phenotypes associated with the disorder. Patients typically suffer from neurological and behavioral difficulties, including language delays and attention difficulties, and some also face immunological, digestive and cardiac problems.

The severity of mental retardation differs by patient and age—sometimes the symptoms are alleviated with age, while for others the symptoms become worse, developing into conditions such as Alzheimer’s disease. “We’d like to understand the molecular pathways responsible for the disease so that we can contribute to the development of effective therapies in the future,” says Kazuhiro Yamakawa, head of the Neurogenetics Laboratory at the RIKEN Brain Science Institute in Wako, Saitama.

In fiscal 2008, Yamakawa’s team secured a grant from the President’s Fund under the category of ‘challenging research’ for a two-year project aimed at developing a highly efficient system to generate transgenic mouse lines for DS research. Their goal is to establish a high-throughput system to generate partial-trisomic DS mouse models and to identify the gene or genes responsible for DS features. In the 14-member laboratory, which also studies epilepsy, Yamakawa and four young researchers participate in this exciting project.

Down syndrome mouse models and lines of research

HC21 carries approximately 360 genes and contains the Down syndrome critical region (DSCR) that many researchers believe is key to the occurrence of DS. HC21 is orthologous (similar by shared ancestry) to part of mouse chromosome 16 (MC16), and several fortuitously generated DS mouse models with partial MC16 have been reported, including Ts1Cje, which has approximately 100 genes and is responsible for milder learning defects; and Ts2Cje, which has approximately 140 genes, partially shared with Ts1Cje, and is responsible for learning defects. Both Ts1Cje and Ts2Cje trisomic segments contain DSCR.

Some researchers believe that the imbalance in chromosomal number for HC21 induces DS by affecting the expressions of genes on the overall genome. Yamakawa and several other groups, however, support a different idea that the initial switch for the disorder is the dosage-dependent overexpression of genes located only on HC21. In 2004, Yamakawa’s team found that the expression levels of genes in the trisomic region of MC16 in Ts1Cje mice were increased by 50%, whereas the levels of other genes on other chromosomes or the normal euploid region of MC16 were almost the same as in normal mice1. Yamakawa adds that many of these overexpressed genes may not result in substantive damage, so identification of a few ‘master’ genes is critical. Some of those genes might also work collectively to contribute to the disorder.

In attempts to identify such master genes, several transgenic mouse models overexpressing individual candidate genes in distinct systems have been developed in other laboratories. However, even though some of the mice models displayed DS-like phenotypes, such as learning disability, the expressions of HC21 or MC16 genes in those models were too excessive (much more than 1.5-fold), ectopic (out of place) or occurred in the wrong developmental timings, making it difficult to compare the results. To improve on this, Yamakawa and his colleagues established a common platform in which heterozygous knockout mice for the HC21-orthologous MC16 candidate gene were mated with partial trisomy MC16 mice such as Ts1Cje. This procedure ensures that the number of copies of the candidate gene is returned to two, while other genes on the trisomic segment retain three copies. Using this system, it is possible to investigate whether any of the DS-like abnormal phenotypes are improved, allowing the contribution of each gene to the biochemical, biophysical or behavioral DS abnormal parameters to be compared impartially. The team has already identified and reported a large number of parameter abnormalities, including decreases in mitochondrial membrane potential and adenosine triphosphate production, increases in reactive oxygen species and kinase activities in Ts1Cje, and enlarged brain ventricles, impaired developmental and adult neurogenesis in Ts1Cje and Ts2Cje. These DS mouse models also display behavioral abnormalities indicative of learning defects. Knockout mice for more than ten HC21-orthologous MC16 genes have been generated, including a model for Dscam—a neural cell adhesion molecule that Yamakawa’s team has long been investigating as a promising candidate for DS mental retardation2. The team is now characterizing mice obtained by mating these model mice with Ts1Cje or Ts2Cje, and evaluating the role of each gene in the DS-like abnormal phenotypes.

A highly efficient system for generating Down syndrome mouse models

Although Yamakawa’s strategy is promising, the generation of many knockout mice is still a daunting task. To implement large-scale analysis more effectively, Yamakawa's group is now establishing a new system that will allow mice to be generated with high efficiency and with free design of partial trisomic segments harboring gene knockouts as desired. In their approach, a selection marker is introduced into MC16 in a mouse primary fibroblast, which is then processed into ‘microcells’, each of which contains, on average, a single chromosome string fused to a special ‘X’ cell. In the cells containing MC16, which are separated out, MC16 can be manipulated to achieve the desired chromosomal segments and gene knockouts with high efficiency. The designed cell containing recombinant MC16 is once again processed into microcells, and then fused into a mouse embryonic stem cell to generate a partial trisomic MC16 mouse. “This system will enable us to not only accelerate our research but also implement experiments that have been impossible, such as the inactivation of multiple genes simultaneously,” Yamakawa says.

Atsushi Shimohata, a member of the technical staff at Yamakawa’s laboratory, and Kenji Amano, a research associate, are currently devoting much of their endeavors to establishing this new system and to removing unnecessary segments from MC16 within the fused cell. Ei-ichi Takaki and Sachie Asada, both research scientists in Yamakawa’s laboratory, are concurrently attempting to establish backup systems, including another type of mouse generating system and a high-efficiency in vitro screening system.

Within 3–5 years, Yamakawa hopes to establish these systems and identify several critical DS genes to elevate DS research to the next level. “We hope that our great passion for this project will eventually lead to alleviating patients’ conditions,” Yamakawa says.

Journal information
1. Amano, K., Sago, H., Uchikawa, C., Suzuki T., Kotliarova, E. S., Nukina N., Epstein J. C. & Yamakawa, K. Dosage-dependent over-expression of genes in the trisomic region of Ts1Cje mouse model for Down syndrome. Human Molecular Genetics 13, 1333–1340 (2004).

2. Amano, K., Fujii, M., Arata, S., Tojima, T., Ogawa, M., Morita, N., Shimohata, A., Furuichi, T., Itohara, S., Kamiguchi, H., Korenberg, J. R., Arata, A. & Yamakawa, K. DSCAM deficiency causes loss of pre-inspiratory neuron synchroneity and perinatal death. Journal of Neuroscience 29, 2984–2996 (2009).

Saeko Okada | Research asia research news
Further information:
http://www.rikenresearch.riken.jp/eng/grants/6199
http://www.researchsea.com

More articles from Life Sciences:

nachricht New photocatalyst speeds up the conversion of carbon dioxide into chemical resources
29.05.2017 | DGIST (Daegu Gyeongbuk Institute of Science and Technology)

nachricht Copper hydroxide nanoparticles provide protection against toxic oxygen radicals in cigarette smoke
29.05.2017 | Johannes Gutenberg-Universität Mainz

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Strathclyde-led research develops world's highest gain high-power laser amplifier

The world's highest gain high power laser amplifier - by many orders of magnitude - has been developed in research led at the University of Strathclyde.

The researchers demonstrated the feasibility of using plasma to amplify short laser pulses of picojoule-level energy up to 100 millijoules, which is a 'gain'...

Im Focus: Can the immune system be boosted against Staphylococcus aureus by delivery of messenger RNA?

Staphylococcus aureus is a feared pathogen (MRSA, multi-resistant S. aureus) due to frequent resistances against many antibiotics, especially in hospital infections. Researchers at the Paul-Ehrlich-Institut have identified immunological processes that prevent a successful immune response directed against the pathogenic agent. The delivery of bacterial proteins with RNA adjuvant or messenger RNA (mRNA) into immune cells allows the re-direction of the immune response towards an active defense against S. aureus. This could be of significant importance for the development of an effective vaccine. PLOS Pathogens has published these research results online on 25 May 2017.

Staphylococcus aureus (S. aureus) is a bacterium that colonizes by far more than half of the skin and the mucosa of adults, usually without causing infections....

Im Focus: A quantum walk of photons

Physicists from the University of Würzburg are capable of generating identical looking single light particles at the push of a button. Two new studies now demonstrate the potential this method holds.

The quantum computer has fuelled the imagination of scientists for decades: It is based on fundamentally different phenomena than a conventional computer....

Im Focus: Turmoil in sluggish electrons’ existence

An international team of physicists has monitored the scattering behaviour of electrons in a non-conducting material in real-time. Their insights could be beneficial for radiotherapy.

We can refer to electrons in non-conducting materials as ‘sluggish’. Typically, they remain fixed in a location, deep inside an atomic composite. It is hence...

Im Focus: Wafer-thin Magnetic Materials Developed for Future Quantum Technologies

Two-dimensional magnetic structures are regarded as a promising material for new types of data storage, since the magnetic properties of individual molecular building blocks can be investigated and modified. For the first time, researchers have now produced a wafer-thin ferrimagnet, in which molecules with different magnetic centers arrange themselves on a gold surface to form a checkerboard pattern. Scientists at the Swiss Nanoscience Institute at the University of Basel and the Paul Scherrer Institute published their findings in the journal Nature Communications.

Ferrimagnets are composed of two centers which are magnetized at different strengths and point in opposing directions. Two-dimensional, quasi-flat ferrimagnets...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Marine Conservation: IASS Contributes to UN Ocean Conference in New York on 5-9 June

24.05.2017 | Event News

AWK Aachen Machine Tool Colloquium 2017: Internet of Production for Agile Enterprises

23.05.2017 | Event News

Dortmund MST Conference presents Individualized Healthcare Solutions with micro and nanotechnology

22.05.2017 | Event News

 
Latest News

New insights into the ancestors of all complex life

29.05.2017 | Earth Sciences

New photocatalyst speeds up the conversion of carbon dioxide into chemical resources

29.05.2017 | Life Sciences

NASA's SDO sees partial eclipse in space

29.05.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>